About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-COX1
A6307G
A6474G
A7222G
A7222G-F1
A7299G
A7445C
A7445G
A7445G-F6
A7445G-F5
A7445G-F4
A7445G-F7
A7445T
C6328T
C6489A
C6489A-F1
C6597A
C6597A-F1
G5906A
G5913A-F1
G5913A
G5920A
G6261A
G6480A
G6480A-F1
G6579A
G6708A
G6955A
G6962A
G7023A
G7444A
G7444A-F21
G7444A-F9
T6459C
T6459C-F1
T6526C
T6547C
T6721C
T6742C
G6930A
Edit by Mitofam Team
-
+
首页
C6328T
# **General Information** | **Position** | **6328** | **Variant** | **m.6328C\>T** | **Locus** | **MT\-CO1** | **Amino\-AcidChange** | **S142F** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \+ | **Heteroplasmy** | \- | **APOGEE2** | Likely\-pathogenic | **Pathogenicity** | Reported \[VUS] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.6328C\>T** variant in MT\-CO1 has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 95%, with a median of 95% overall; affected carriers showed mutation loads from 95%, with a median of 95%. The main clinical manifestations among affected carriers included exercise intolerance, cardiac arrest, fatigue, hypertrophic cardiomyopathy, muscle weakness, and stroke\-like episode. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6328 | m.6328C\>T | C6328T\-F1 | Italy | Mitochondrial cardioencephalomyopathy resembling MELAS | ND | ND | 2006 | [16284789](https://pubmed.ncbi.nlm.nih.gov/16284789/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6328 | m.6328C\>T | C6328T\-F1 | C6328T\-F1\-P1 | Uninf | F | Y | Y | D | 30 | / | \>95% | / | / | Exercise intolerance; fatigue; muscle weakness; hypertrophic cardiomyopathy; stroke\-like episode; cardiac arrest | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月26日 16:25
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)